A Medigene platform · Omnichannel HCP engagement

One knowledge network for everyone in the care chain

A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.

Who MedShorts servesProgrammes for pharma

The MedShorts network

DoctorsClinical updates in five minutes or less
PharmacistsDispensing, counselling and safety capsules
Field forceProduct knowledge, certification and shareable links
One dashboardReach, engagement and learning, by audience
MedShorts 360 · Today

Today's news, 11 November 2026

One new story for each specialty, every morning: short, sourced and readable between patients.

CardiologyCardiology

Lp(a)HORIZON: pelacarsen cuts lipoprotein(a) by 78% but does not reduce cardiovascular events

In 8,323 patients with established cardiovascular disease and high Lp(a), monthly pelacarsen lowered Lp(a) sharply but MACE rates were the same as placebo (HR 1.02). Experts say Lp(a) testing remains useful for risk assessment.

TCTMD
DiabetologyDiabetology

US FDA adds NAION eye warning to labels of all GLP-1 receptor agonists, including tirzepatide

The FDA now requires a warning on non-arteritic anterior ischaemic optic neuropathy for all GLP-1 receptor agonists. Absolute risk is low, but patients should report sudden painless vision loss in one eye and be referred promptly.

US Food and Drug Administration
NephrologyNephrology

Inpatient ibuprofen linked to more acute kidney injury than oxycodone, mainly after surgery or in ICU

In 78,656 hospitalised adults, ibuprofen for acute pain was associated with 22% higher AKI rates than oxycodone, with excess risk concentrated in postoperative and critically ill patients. Low-risk patients showed no excess.

JAMA Network Open
NeurologyNeurology

US FDA approves asundexian, first factor XIa inhibitor for secondary prevention after ischaemic stroke

The FDA has approved oral asundexian 50 mg with antiplatelet therapy after non-cardioembolic ischaemic stroke or high-risk TIA. In OCEANIC-STROKE it cut ischaemic stroke by 26% without a significant rise in major bleeding.

NeurologyLive
UrologyUrology

Suction access sheaths in RIRS linked to better stone clearance and less fever: meta-analysis

An updated meta-analysis of 29 studies (5,604 patients) found suction ureteral access sheaths roughly halved residual fragments, fever and sepsis versus traditional sheaths in RIRS, though most evidence is observational.

World Journal of Urology (via PubMed Central)
PsychiatryPsychiatry

Ketamine-assisted mindfulness therapy may boost body awareness linked to lower opioid craving

A secondary analysis of a 68-patient trial found that adding two ketamine-assisted sessions to mindfulness therapy in people on buprenorphine increased self-reported body awareness, which tracked with lower opioid craving later.

Medical Dialogues
PulmonologyPulmonology

BRONCHIOLE trial: adding metoprolol does not improve outcomes in COPD without heart disease

In a 1,695-patient pragmatic trial, metoprolol added to standard care in COPD patients without cardiovascular disease did not significantly reduce exacerbations, cardiovascular events or death over one year.

Healio
Critical CareCritical Care

Preexisting atrial fibrillation linked to more ICU delirium in a 50,667-patient cohort

In a single-centre US cohort of 50,667 adult ICU patients, those with preexisting atrial fibrillation spent a larger share of ICU days delirious, an association that persisted after adjustment for baseline risk.

Medical Dialogues
GastroenterologyGastroenterology

AASLD expert opinion on hepatitis delta: test every HBsAg-positive patient at least once

A new AASLD Expert-Based Practice Opinion in Hepatology advises one-time HDV antibody testing for everyone who is HBsAg positive, RNA confirmation, elastography, six-monthly liver cancer surveillance and consideration of antiviral therapy.

AASLD (American Association for the Study of Liver Diseases)
DermatologyDermatology

Air pollution tied to more atopic dermatitis and clinic visits in children: JAMA Pediatrics review

A meta-analysis of 52 observational studies found that higher NO2, SO2, PM10 and PM2.5 levels were probably linked to higher atopic dermatitis prevalence and more outpatient visits in children, while evidence on new cases and severity was mixed.

JAMA Pediatrics
OphthalmologyOphthalmology

Donor diabetes did not lower DMEK graft success: DEKS named JAMA Ophthalmology trial of the year

JAMA Ophthalmology has named the Diabetes Endothelial Keratoplasty Study its first Clinical Trial of the Year. The trial found one-year DMEK graft success was about 96% to 97% whether or not the corneal donor had diabetes.

JAMA Ophthalmology
ENTENT

Poorer hearing linked to slightly thinner retina in 32,613 UK Biobank adults: IOVS study

A cross-sectional UK Biobank analysis found that worse speech-in-noise hearing was associated with modestly thinner macular and inner retinal layers. The differences were very small and the design cannot show cause or direction.

Hearing Health & Technology Matters
OrthopaedicsOrthopaedics

Low back pain and low mood predict persistent walking difficulty a year after knee replacement

In a Canadian cohort of 1,296 patients who had walking difficulty before total knee arthroplasty, 60.6% had none a year later. Depression and low back pain lowered the odds of recovery, while self-efficacy and social support raised them.

ACR Convergence 2026 (ACR Meeting Abstracts)
GynaecologyGynaecology

Familial hypercholesterolaemia linked to modestly higher pre-eclampsia rates in European study

Women with familial hypercholesterolaemia reported pre-eclampsia more often than matched controls (11% vs 7%), while other reproductive and pregnancy outcomes were similar, a Dutch-Norwegian study found.

Medical Dialogues
PaediatricsPaediatrics

Children and teens see thousands of mostly unhealthy food ads a year on phones, JAMA Pediatrics study finds

Screen-capture data from 1,011 US youth aged 8 to 17 suggested a median of about 3,900 food marketing exposures a year, mostly on social media; over 90% of packaged products shown failed a nutrient standard.

JAMA Pediatrics
SurgerySurgery

Antibiotic prophylaxis in head and neck surgery varies widely and often runs long, global survey finds

A survey of 468 head and neck surgeons in 46 countries found routine antibiotics in clean thyroid surgery and prolonged courses after clean-contaminated cancer surgery were common, and having a guideline did not mean shorter courses.

JAMA Network Open
General MedicineGeneral Medicine

Pharmacist-led deprescribing of sedatives and anticholinergics in older inpatients gives modest, brief gain

In a stepped-wedge trial in six Australian hospitals involving 4,827 inpatients aged 65 or older, adding stewardship pharmacists raised deprescribing of sedative and anticholinergic drugs by 5.3 percentage points, but the gain faded once they were withdrawn.

JAMA Internal Medicine
17 new today · 17 latest storiesSee all MedShorts 360 stories →
Get the MedShorts app

Add MedShorts to your phone's home screen: today's stories in one tap, full screen, no app store needed.

Why MedShorts is changing

Medical communication has outgrown the single doctor visit

Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.

MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.

The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.

What changes with MedShorts

01
From one audience to threeContent written separately for prescribers, dispensers and representatives, from the same evidence base.
02
From campaigns to a programmeA planned calendar of short updates across the year instead of one-off mailers.
03
From clicks to insightEngagement data by specialty, geography and audience, fed back into the next cycle.
04
From information to learningQuizzes, certification and links to Medigene CME where a deeper course exists.
Who MedShorts serves

Built for three roles that shape every treatment

Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.

For doctors

Clinical knowledge between consultations

Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.

  • Read or watch in under five minutes
  • Specialty-specific libraries
  • Patient education material to share
MedShorts for doctors →
For pharmacists

Confident counselling at the counter

Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.

  • Counselling scripts and checklists
  • Drug interaction and safety alerts
  • Available in English and Hindi
MedShorts for pharmacists →
For field force

Scientific confidence in every call

Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.

  • Daily five-minute learning bursts
  • Quizzes and product certification
  • Compliant, trackable sharing
MedShorts for field force →
The connected care chain

One message, from the representative to the patient

When all three roles learn from the same source, the patient hears one consistent story about their treatment.

Field representative

Learns the evidence, passes certification, shares an approved MedShorts link.

Doctor

Reviews the update in minutes, prescribes with the latest guidance, shares patient material.

Pharmacist

Dispenses correctly and counsels on dose, timing, side-effects and adherence.

MedShorts hubShared evidence base, medical review, multi-language content and one analytics layer across all three audiences.See the programme model
Strategic pillars

Five things MedShorts is built on

Short, evidence-led content

Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.

Reach where people already are

Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.

Learning, not just reading

Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.

Insight for brand teams

Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.

Trust and compliance

Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.

India-first delivery

Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.

How it works

Receive, open, learn, act

Receive

A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.

Open

One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.

Learn

Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.

Act

Apply it in practice, share patient material, or continue to a full CME course.

Measure

Engagement flows into the brand dashboard and shapes the next content cycle.

Content formats

The right format for every minute available

Clinical shorts

Two-to-three-minute reads on a single clinical question.

KOL video bites

Expert perspectives in three-to-five-minute clips.

Journal digests

Landmark and recent trials summarised with key numbers.

Guideline snapshots

What changed, and what it means in clinic.

Quizzes & case challenges

Test and reinforce, with instant explanations.

Patient education

Leaflets and videos doctors and pharmacists can share.

Interactive tools

Lung-sound and ECG trainers, calculators and checklists.

Safety alerts

Interaction, storage and pharmacovigilance reminders.

Already live

A growing library across specialties

MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.

The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.

NeurologyCardio-metabolicRespiratoryOrthopaedicsOncologyWomen's healthCritical careDermatologyDentalOphthalmology

Browse the content library

Fewer, shorter and better-targeted messages, shared by everyone around the patient, do more than any single detailing call.The idea behind the MedShorts network

Bring your brand science to the whole care chain

Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.

Talk to our team